large b-cell lymphoma – Car-T Central

Relapsed or Refractory Large B-Cell Lymphoma and the TRANSFORM study

TRANSFORM is a global, randomized, phase III study comparing the efficacy and safety of standard of care against liso-cel in patients with relapsed or refractory large b-cell lymphoma

High-Risk Large B-Cell Lymphoma and the ZUMA-12 study

ZUMA-12 is a single-arm phase II trial in which 42 patients received axicabtagene ciloleucel as first-line therapy in high-risk large B-cell lymphoma